Molly Ogorman
Pediatric Gastroenterology · Slc, UTNPI 1144339391
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$704,327in research payments, 2019–2025
Across 241 payments — averaging $2922.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$458K
- Pfizer$73K
- QOL Medical, LLC$69K
- Shire North American Group Inc$64K
- Bristol Myers Squibb$31K
- Merck$6K
- plus $3K from 1 others
How this compares
Too few pediatric gastroenterology providers in Utahto place this figure against a meaningful peer group, so we don't.
Other pediatric gastroenterology in Slc
- Jacob RobsonSalt Lake City$90K
- Linda BookSalt Lake City$16K
- Steven WuSalt Lake City$703
- Raza PatelSalt Lake City$387
- William JacksonSalt Lake City$166
- Shivani KamalSalt Lake City$146
- John PohlSalt Lake City$80
- Catalina Jaramillo CastrillonSalt Lake City$76
- Lance FrankSalt Lake City$53
- Stephanie SeguraSalt Lake City$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.